Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Comi G, Alroughani R, Boster AL, Bass AD, et al. Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies. Mult Scler 2019 Nov 25:1352458519888610. doi: 10.1177/1352458519888610.
PMID: 31762387

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016